Relationship Between HIV Stage and Psychomotor Speed Neurocognitive Score at a Kenyan Sub-county Hospital

Overview

Journal Afr J Prim Health Care Fam Med

Specialty Public Health

Date 2016 Sep 10

PMID 27608675

Citations 1

Authors

Rachael N Kinuthia

Benson N Gakinya

Joseph M Thigiti

Affiliations

Soon will be listed here.

Abstract

Background: Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) is associated with cognitive impairment which affects psychomotor speed. Psychomotor slowing is a predictor of dementia and death in people living with HIV and AIDS. The purpose of this study was to assess the relationship between HIV disease stage and psychomotor speed neurocognitive score which will add to the body of knowledge required to manage patients with HIV and AIDS.

Objective: To determine the relationship between psychomotor speed neurocognitive score and the HIV disease stage in adults at initiation of care.

Setting: This study was conducted at Kangundo Sub-county hospital comprehensive care centre.

Methods: This was a cross-sectional study. All HIV seropositive patients aged 18 to 50 years recently initiated into care were studied. A pretested questionnaire was used to collect data. The World Health Organization (WHO) stage was used during data collection to classify study participants into asymptomatic and symptomatic groups. The grooved pegboard test was used to obtain psychomotor speed neurocognitive scores. Descriptive statistics were used to summarise data. Mann-Whitney U test, Spearman's rho and multiple linear regression were employed in the analysis; p-value of 0.05 was considered significant.

Results: The WHO stage did not have a significant effect on the psychomotor speed neurocognitive score (p ≥ 0.05). The CD4 count had a significant effect on psychomotor speed neurocognitive score (p = 0.001).

Conclusions: There was a significant correlation between CD4 counts and psychomotor speed neurocognitive score. Efforts should be made to ensure that the CD4 counts of people living with HIV and AIDS do not continue to fall after initiation into care in order to preserve psychomotor function.

Citing Articles

Effects of HIV infection, antiretroviral therapy, and immune status on the speed of information processing and complex motor functions in adult Cameroonians.

Kanmogne G, Fonsah J, Umlauf A, Moul J, Doh R, Kengne A Sci Rep. 2020; 10(1):14016.

PMID: 32820234 PMC: 7441321. DOI: 10.1038/s41598-020-70981-4.

References

Sacktor N, Bacellar H, Hoover D, Selnes O, Miller E, Dal Pan G . Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol. 1996; 2(6):404-10. DOI: 10.3109/13550289609146906. View

Lawler K, Jeremiah K, Mosepele M, Ratcliffe S, Cherry C, Seloilwe E . Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. PLoS One. 2011; 6(2):e17233. PMC: 3041805. DOI: 10.1371/journal.pone.0017233. View

Joska J, Westgarth-Taylor J, Myer L, Hoare J, Thomas K, Combrinck M . Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav. 2010; 15(6):1197-203. DOI: 10.1007/s10461-010-9744-6. View

Mills E, Singh S, Nelson B, Nachega J . The impact of conflict on HIV/AIDS in sub-Saharan Africa. Int J STD AIDS. 2006; 17(11):713-7. DOI: 10.1258/095646206778691077. View

Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S . Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. 2006; 67(2):311-4. DOI: 10.1212/01.wnl.0000225183.74521.72. View

Vo Q, Cox C, Li X, Jacobson L, McKaig R, Sacktor N . Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study. J Neurovirol. 2012; 19(1):24-31. PMC: 3568242. DOI: 10.1007/s13365-012-0136-8. View

Cysique L, Maruff P, Darby D, Brew B . The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2005; 21(2):185-94. DOI: 10.1016/j.acn.2005.07.011. View

Sacktor N, Skolasky R, Tarwater P, McArthur J, Selnes O, Becker J . Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology. 2003; 61(4):567-9. DOI: 10.1212/01.wnl.0000076477.71313.6e. View

Robertson K, Liner J, Hakim J, Sankale J, Grant I, Letendre S . NeuroAIDS in Africa. J Neurovirol. 2010; 16(3):189-202. PMC: 3549534. DOI: 10.3109/13550284.2010.489597. View

10.

Sacktor N, Nakasujja N, Robertson K, Clifford D . HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity. Nat Clin Pract Neurol. 2007; 3(8):436-43. DOI: 10.1038/ncpneuro0559. View

11.

Clifford D, Mitike M, Mekonnen Y, Zhang J, Zenebe G, Melaku Z . Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol. 2007; 13(1):67-72. DOI: 10.1080/13550280601169837. View

12.

Sacktor N, Skolasky R, Cox C, Selnes O, Becker J, Cohen B . Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol. 2010; 16(5):335-41. PMC: 3068912. DOI: 10.3109/13550284.2010.504249. View

13.

von Giesen H, Koller H, Theisen A, Arendt G . Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients. J Acquir Immune Defic Syndr. 2002; 29(4):363-7. DOI: 10.1097/00126334-200204010-00006. View

14.

Kanmogne G, Kuate C, Cysique L, Fonsah J, Eta S, Doh R . HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol. 2010; 10:60. PMC: 2912842. DOI: 10.1186/1471-2377-10-60. View

15.

Hinkin C, Castellon S, Durvasula R, Hardy D, Lam M, Mason K . Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002; 59(12):1944-50. PMC: 2871670. DOI: 10.1212/01.wnl.0000038347.48137.67. View

16.

Baldewicz T, Leserman J, Silva S, Petitto J, Golden R, Perkins D . Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Behav. 2004; 8(3):345-55. DOI: 10.1023/B:AIBE.0000044081.42034.54. View

17.

Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck G . Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One. 2012; 7(3):e32898. PMC: 3296754. DOI: 10.1371/journal.pone.0032898. View

18.

Brooks R, Klosinski L . Assisting persons living with HIV/AIDS to return to work: programmatic steps for AIDS service organizations. AIDS Educ Prev. 1999; 11(3):212-23. View

19.

Stern Y, McDermott M, Albert S, Palumbo D, Selnes O, McArthur J . Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol. 2001; 58(3):473-9. DOI: 10.1001/archneur.58.3.473. View

20.

De Vogli R, Birbeck G . Potential impact of adjustment policies on vulnerability of women and children to HIV/AIDS in sub-Saharan Africa. J Health Popul Nutr. 2005; 23(2):105-20. View